Plx Pharma Drug Patent Portfolio
Plx Pharma owns 1 orange book drug protected by 7 US patents Given below is the list of Plx Pharma's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10646431 | PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same | 29 Sep, 2032 | Active |
| US10786444 | PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same | 29 Sep, 2032 | Active |
| US9216150 | pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same | 29 Sep, 2032 | Active |
| US9226892 | pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same | 29 Sep, 2032 | Active |
| US8865187 | Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity | 23 Mar, 2022 | Expired |
| US9101637 | Methods of treating inflammation with compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity | 23 Mar, 2022 | Expired |
| US9351984 | Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity | 19 Dec, 2021 | Expired |
Latest Legal Activities on Plx Pharma's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Plx Pharma.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 14 Mar, 2024 | US10786444 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 25 Oct, 2023 | US10646431 |
|
Expire Patent
Critical
| 18 Sep, 2023 | US9101637 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 02 Aug, 2023 | US9226892 |
| 7.5 yr surcharge - late pmt w/in 6 mo, Small Entity | 02 Aug, 2023 | US9226892 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 07 Jun, 2023 | US9216150 |
|
Maintenance Fee Reminder Mailed
Critical
| 03 Apr, 2023 | US9101637 |
|
Expire Patent
Critical
| 28 Nov, 2022 | US8865187 |
|
Maintenance Fee Reminder Mailed
Critical
| 13 Jun, 2022 | US8865187 |
|
Recordation of Patent Grant Mailed
Critical
| 29 Sep, 2020 | US10786444 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 29 Sep, 2020 | US10786444 |
|
Email Notification
Critical
| 15 Sep, 2020 | US10786444 |
|
Issue Notification Mailed
Critical
| 09 Sep, 2020 | US10786444 |
|
Application Is Considered Ready for Issue
Critical
| 17 Aug, 2020 | US10786444 |
| Dispatch to FDC | 17 Aug, 2020 | US10786444 |
Plx Pharma's Drug Patent Litigations
Plx Pharma's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Jan 02, 2014, against patent number US8865187. The petitioner , challenged the validity of this patent, with Lenard M. Lichtenberger as the respondent. Click below to track the latest information on how companies are challenging Plx Pharma's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US8865187 | January, 2014 |
Decision
(17 Jun, 2014)
| Lenard M. Lichtenberger | |
Plx Pharma's Family Patents
Plx Pharma Drug List
Given below is the complete list of Plx Pharma's drugs and the patents protecting them.
1. Vazalore
Vazalore is protected by 7 patents, out of which 3 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10646431 | PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same |
29 Sep, 2032
(7 years from now)
| Active |
| US10786444 | PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same |
29 Sep, 2032
(7 years from now)
| Active |
| US9216150 | pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same |
29 Sep, 2032
(7 years from now)
| Active |
| US9226892 | pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same |
29 Sep, 2032
(7 years from now)
| Active |
| US8865187 | Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
23 Mar, 2022
(2 years ago)
| Expired |
| US9101637 | Methods of treating inflammation with compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
23 Mar, 2022
(2 years ago)
| Expired |
| US9351984 | Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
19 Dec, 2021
(3 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vazalore's drug page